Global Inactivated Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Inactivated Polio Vaccine market size was valued at USD 708.4 million in 2023 and is forecast to a readjusted size of USD 945.6 million by 2030 with a CAGR of 4.2% during review period.

Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Inactivated Polio Vaccine industry chain, the market status of Pediatrics (Government, Private Sector), Adults (Government, Private Sector), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Inactivated Polio Vaccine.

Regionally, the report analyzes the Inactivated Polio Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Inactivated Polio Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Inactivated Polio Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Inactivated Polio Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Government, Private Sector).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Inactivated Polio Vaccine market.

Regional Analysis: The report involves examining the Inactivated Polio Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Inactivated Polio Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Inactivated Polio Vaccine:
Company Analysis: Report covers individual Inactivated Polio Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Inactivated Polio Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pediatrics, Adults).

Technology Analysis: Report covers specific technologies relevant to Inactivated Polio Vaccine. It assesses the current state, advancements, and potential future developments in Inactivated Polio Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Inactivated Polio Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Inactivated Polio Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Government
    Private Sector

Market segment by Application
    Pediatrics
    Adults

Major players covered
    Sanofi
    GSK
    Bibcol
    Serum Institute
    Tiantan Biological
    Panacea Biotec
    Bio-Med
    Halfkin Bio-Pharmaceuticals

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inactivated Polio Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inactivated Polio Vaccine, with price, sales, revenue and global market share of Inactivated Polio Vaccine from 2019 to 2024.
Chapter 3, the Inactivated Polio Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inactivated Polio Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Inactivated Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inactivated Polio Vaccine.
Chapter 14 and 15, to describe Inactivated Polio Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Inactivated Polio Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Inactivated Polio Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Government
        1.3.3 Private Sector
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Inactivated Polio Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Pediatrics
        1.4.3 Adults
    1.5 Global Inactivated Polio Vaccine Market Size & Forecast
        1.5.1 Global Inactivated Polio Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Inactivated Polio Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Inactivated Polio Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Inactivated Polio Vaccine Product and Services
        2.1.4 Sanofi Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Sanofi Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Inactivated Polio Vaccine Product and Services
        2.2.4 GSK Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 GSK Recent Developments/Updates
    2.3 Bibcol
        2.3.1 Bibcol Details
        2.3.2 Bibcol Major Business
        2.3.3 Bibcol Inactivated Polio Vaccine Product and Services
        2.3.4 Bibcol Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bibcol Recent Developments/Updates
    2.4 Serum Institute
        2.4.1 Serum Institute Details
        2.4.2 Serum Institute Major Business
        2.4.3 Serum Institute Inactivated Polio Vaccine Product and Services
        2.4.4 Serum Institute Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Serum Institute Recent Developments/Updates
    2.5 Tiantan Biological
        2.5.1 Tiantan Biological Details
        2.5.2 Tiantan Biological Major Business
        2.5.3 Tiantan Biological Inactivated Polio Vaccine Product and Services
        2.5.4 Tiantan Biological Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Tiantan Biological Recent Developments/Updates
    2.6 Panacea Biotec
        2.6.1 Panacea Biotec Details
        2.6.2 Panacea Biotec Major Business
        2.6.3 Panacea Biotec Inactivated Polio Vaccine Product and Services
        2.6.4 Panacea Biotec Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Panacea Biotec Recent Developments/Updates
    2.7 Bio-Med
        2.7.1 Bio-Med Details
        2.7.2 Bio-Med Major Business
        2.7.3 Bio-Med Inactivated Polio Vaccine Product and Services
        2.7.4 Bio-Med Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Bio-Med Recent Developments/Updates
    2.8 Halfkin Bio-Pharmaceuticals
        2.8.1 Halfkin Bio-Pharmaceuticals Details
        2.8.2 Halfkin Bio-Pharmaceuticals Major Business
        2.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product and Services
        2.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Inactivated Polio Vaccine by Manufacturer
    3.1 Global Inactivated Polio Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Inactivated Polio Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Inactivated Polio Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Inactivated Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Inactivated Polio Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 Inactivated Polio Vaccine Manufacturer Market Share in 2023
    3.5 Inactivated Polio Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Inactivated Polio Vaccine Market: Region Footprint
        3.5.2 Inactivated Polio Vaccine Market: Company Product Type Footprint
        3.5.3 Inactivated Polio Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Inactivated Polio Vaccine Market Size by Region
        4.1.1 Global Inactivated Polio Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Inactivated Polio Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Inactivated Polio Vaccine Average Price by Region (2019-2030)
    4.2 North America Inactivated Polio Vaccine Consumption Value (2019-2030)
    4.3 Europe Inactivated Polio Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Inactivated Polio Vaccine Consumption Value (2019-2030)
    4.5 South America Inactivated Polio Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa Inactivated Polio Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Inactivated Polio Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Inactivated Polio Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Inactivated Polio Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Inactivated Polio Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Inactivated Polio Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Inactivated Polio Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Inactivated Polio Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Inactivated Polio Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Inactivated Polio Vaccine Market Size by Country
        7.3.1 North America Inactivated Polio Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Inactivated Polio Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Inactivated Polio Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Inactivated Polio Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Inactivated Polio Vaccine Market Size by Country
        8.3.1 Europe Inactivated Polio Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Inactivated Polio Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Inactivated Polio Vaccine Market Size by Region
        9.3.1 Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Inactivated Polio Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Inactivated Polio Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Inactivated Polio Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Inactivated Polio Vaccine Market Size by Country
        10.3.1 South America Inactivated Polio Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Inactivated Polio Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Inactivated Polio Vaccine Market Size by Country
        11.3.1 Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Inactivated Polio Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Inactivated Polio Vaccine Market Drivers
    12.2 Inactivated Polio Vaccine Market Restraints
    12.3 Inactivated Polio Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Inactivated Polio Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Inactivated Polio Vaccine
    13.3 Inactivated Polio Vaccine Production Process
    13.4 Inactivated Polio Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Inactivated Polio Vaccine Typical Distributors
    14.3 Inactivated Polio Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Inactivated Polio Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Inactivated Polio Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Inactivated Polio Vaccine Product and Services
    Table 6. Sanofi Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Sanofi Recent Developments/Updates
    Table 8. GSK Basic Information, Manufacturing Base and Competitors
    Table 9. GSK Major Business
    Table 10. GSK Inactivated Polio Vaccine Product and Services
    Table 11. GSK Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. GSK Recent Developments/Updates
    Table 13. Bibcol Basic Information, Manufacturing Base and Competitors
    Table 14. Bibcol Major Business
    Table 15. Bibcol Inactivated Polio Vaccine Product and Services
    Table 16. Bibcol Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Bibcol Recent Developments/Updates
    Table 18. Serum Institute Basic Information, Manufacturing Base and Competitors
    Table 19. Serum Institute Major Business
    Table 20. Serum Institute Inactivated Polio Vaccine Product and Services
    Table 21. Serum Institute Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Serum Institute Recent Developments/Updates
    Table 23. Tiantan Biological Basic Information, Manufacturing Base and Competitors
    Table 24. Tiantan Biological Major Business
    Table 25. Tiantan Biological Inactivated Polio Vaccine Product and Services
    Table 26. Tiantan Biological Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Tiantan Biological Recent Developments/Updates
    Table 28. Panacea Biotec Basic Information, Manufacturing Base and Competitors
    Table 29. Panacea Biotec Major Business
    Table 30. Panacea Biotec Inactivated Polio Vaccine Product and Services
    Table 31. Panacea Biotec Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Panacea Biotec Recent Developments/Updates
    Table 33. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 34. Bio-Med Major Business
    Table 35. Bio-Med Inactivated Polio Vaccine Product and Services
    Table 36. Bio-Med Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Bio-Med Recent Developments/Updates
    Table 38. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 39. Halfkin Bio-Pharmaceuticals Major Business
    Table 40. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product and Services
    Table 41. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
    Table 43. Global Inactivated Polio Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Dose)
    Table 44. Global Inactivated Polio Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 45. Global Inactivated Polio Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
    Table 46. Market Position of Manufacturers in Inactivated Polio Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 47. Head Office and Inactivated Polio Vaccine Production Site of Key Manufacturer
    Table 48. Inactivated Polio Vaccine Market: Company Product Type Footprint
    Table 49. Inactivated Polio Vaccine Market: Company Product Application Footprint
    Table 50. Inactivated Polio Vaccine New Market Entrants and Barriers to Market Entry
    Table 51. Inactivated Polio Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Inactivated Polio Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
    Table 53. Global Inactivated Polio Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
    Table 54. Global Inactivated Polio Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 55. Global Inactivated Polio Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 56. Global Inactivated Polio Vaccine Average Price by Region (2019-2024) & (US$/Dose)
    Table 57. Global Inactivated Polio Vaccine Average Price by Region (2025-2030) & (US$/Dose)
    Table 58. Global Inactivated Polio Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
    Table 59. Global Inactivated Polio Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
    Table 60. Global Inactivated Polio Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 61. Global Inactivated Polio Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 62. Global Inactivated Polio Vaccine Average Price by Type (2019-2024) & (US$/Dose)
    Table 63. Global Inactivated Polio Vaccine Average Price by Type (2025-2030) & (US$/Dose)
    Table 64. Global Inactivated Polio Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
    Table 65. Global Inactivated Polio Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
    Table 66. Global Inactivated Polio Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. Global Inactivated Polio Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. Global Inactivated Polio Vaccine Average Price by Application (2019-2024) & (US$/Dose)
    Table 69. Global Inactivated Polio Vaccine Average Price by Application (2025-2030) & (US$/Dose)
    Table 70. North America Inactivated Polio Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
    Table 71. North America Inactivated Polio Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
    Table 72. North America Inactivated Polio Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
    Table 73. North America Inactivated Polio Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
    Table 74. North America Inactivated Polio Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
    Table 75. North America Inactivated Polio Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
    Table 76. North America Inactivated Polio Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 77. North America Inactivated Polio Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 78. Europe Inactivated Polio Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
    Table 79. Europe Inactivated Polio Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
    Table 80. Europe Inactivated Polio Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
    Table 81. Europe Inactivated Polio Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
    Table 82. Europe Inactivated Polio Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
    Table 83. Europe Inactivated Polio Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
    Table 84. Europe Inactivated Polio Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Inactivated Polio Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
    Table 87. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
    Table 88. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
    Table 89. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
    Table 90. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
    Table 91. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
    Table 92. Asia-Pacific Inactivated Polio Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 93. Asia-Pacific Inactivated Polio Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 94. South America Inactivated Polio Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
    Table 95. South America Inactivated Polio Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
    Table 96. South America Inactivated Polio Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
    Table 97. South America Inactivated Polio Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
    Table 98. South America Inactivated Polio Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
    Table 99. South America Inactivated Polio Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
    Table 100. South America Inactivated Polio Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 101. South America Inactivated Polio Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
    Table 103. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
    Table 104. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
    Table 105. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
    Table 106. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
    Table 107. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
    Table 108. Middle East & Africa Inactivated Polio Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Inactivated Polio Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 110. Inactivated Polio Vaccine Raw Material
    Table 111. Key Manufacturers of Inactivated Polio Vaccine Raw Materials
    Table 112. Inactivated Polio Vaccine Typical Distributors
    Table 113. Inactivated Polio Vaccine Typical Customers
List of Figures
    Figure 1. Inactivated Polio Vaccine Picture
    Figure 2. Global Inactivated Polio Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Inactivated Polio Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. Government Examples
    Figure 5. Private Sector Examples
    Figure 6. Global Inactivated Polio Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Inactivated Polio Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. Pediatrics Examples
    Figure 9. Adults Examples
    Figure 10. Global Inactivated Polio Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Inactivated Polio Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Inactivated Polio Vaccine Sales Quantity (2019-2030) & (K Dose)
    Figure 13. Global Inactivated Polio Vaccine Average Price (2019-2030) & (US$/Dose)
    Figure 14. Global Inactivated Polio Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Inactivated Polio Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Inactivated Polio Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Inactivated Polio Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Inactivated Polio Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Inactivated Polio Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Inactivated Polio Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Inactivated Polio Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Inactivated Polio Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Inactivated Polio Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Inactivated Polio Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Inactivated Polio Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Inactivated Polio Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Inactivated Polio Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Inactivated Polio Vaccine Average Price by Type (2019-2030) & (US$/Dose)
    Figure 29. Global Inactivated Polio Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Inactivated Polio Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Inactivated Polio Vaccine Average Price by Application (2019-2030) & (US$/Dose)
    Figure 32. North America Inactivated Polio Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Inactivated Polio Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Inactivated Polio Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Inactivated Polio Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Inactivated Polio Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Inactivated Polio Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Inactivated Polio Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Inactivated Polio Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Inactivated Polio Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Inactivated Polio Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Inactivated Polio Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Inactivated Polio Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Inactivated Polio Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Inactivated Polio Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Inactivated Polio Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Inactivated Polio Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Inactivated Polio Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Inactivated Polio Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Inactivated Polio Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Inactivated Polio Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Inactivated Polio Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Inactivated Polio Vaccine Market Drivers
    Figure 73. Inactivated Polio Vaccine Market Restraints
    Figure 74. Inactivated Polio Vaccine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Inactivated Polio Vaccine in 2023
    Figure 77. Manufacturing Process Analysis of Inactivated Polio Vaccine
    Figure 78. Inactivated Polio Vaccine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals